These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Yo jyo hen shi ko, a novel Chinese herbal, prevents nonalcoholic steatohepatitis in ob/ob mice fed a high fat or methionine-choline-deficient diet. de Lima VM, de Oliveira CP, Sawada LY, Barbeiro HV, de Mello ES, Soriano FG, Alves VA, Caldwell SH, Carrilho FJ. Liver Int; 2007 Mar; 27(2):227-34. PubMed ID: 17311618 [Abstract] [Full Text] [Related]
27. Thioredoxin-binding protein-2 deficiency enhances methionine-choline deficient diet-induced hepatic steatosis but inhibits steatohepatitis in mice. Ahsan MK, Okuyama H, Hoshino Y, Oka S, Masutani H, Yodoi J, Nakamura H. Antioxid Redox Signal; 2009 Oct; 11(10):2573-84. PubMed ID: 19764881 [Abstract] [Full Text] [Related]
28. A methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation. Pelz S, Stock P, Brückner S, Christ B. Exp Cell Res; 2012 Feb 01; 318(3):276-87. PubMed ID: 22108588 [Abstract] [Full Text] [Related]
32. Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model. Veteläinen R, van Vliet A, van Gulik TM. J Gastroenterol Hepatol; 2007 Sep 01; 22(9):1526-33. PubMed ID: 17716355 [Abstract] [Full Text] [Related]
34. Reciprocal congenics defining individual quantitative trait Loci for sedative/hypnotic sensitivity to ethanol. Bennett B, Beeson M, Gordon L, Johnson TE. Alcohol Clin Exp Res; 2002 Feb 01; 26(2):149-57. PubMed ID: 11964553 [Abstract] [Full Text] [Related]
35. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice. Nan YM, Fu N, Wu WJ, Liang BL, Wang RQ, Zhao SX, Zhao JM, Yu J. Scand J Gastroenterol; 2009 Feb 01; 44(3):358-65. PubMed ID: 18991162 [Abstract] [Full Text] [Related]
36. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease. Pathil A, Mueller J, Warth A, Chamulitrat W, Stremmel W. Hepatology; 2012 May 01; 55(5):1369-78. PubMed ID: 22183915 [Abstract] [Full Text] [Related]
38. Thioacetamide-induced hepatic damage in a rat nutritional model of steatohepatitis. Avni Y, Shirin H, Aeed H, Matas Z, Shahmurov M, Birkenfeld S, Bruck R. J Med; 2003 May 01; 34(1-6):121-37. PubMed ID: 17682318 [Abstract] [Full Text] [Related]
40. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice. Cong WN, Tao RY, Tian JY, Liu GT, Ye F. Life Sci; 2008 May 07; 82(19-20):983-90. PubMed ID: 18417155 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]